Apriori Bio, Inc.: Translational Immunology Co-Op

Work Period: January 2027 to June 2027. This is a full-time, 40 hours per week position with 5 days in office.

Are you ready to be part of a pioneering biotech company on the frontline of developing solutions against rapidly evolving viruses like influenza and SARS-CoV-2? At Apriori Bio, we're creating a safer world through resilient vaccines and advanced antibody therapeutics using our cutting-edge Octavia™ platform. 

As a member of our translational immunology team, you'll explore the forefront of scientific discovery—from developing novel assays to predict viral escape routes to evaluating the vaccine-elicited immune response and coverage of emerging variants

Apriori Bio, Inc. was founded by Flagship Pioneering’s venture creation engine that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.

Welcome to the Flagship Pioneering Co-Op Program for the cohort dreaming big and taking courageous leaps. You’ll join fellow peers across our ecosystem of companies and learn firsthand how we build first-in-category companies. You’ll have access to enrichment sessions, a dedicated professional development track, and a mentor that help guide you toward your next step. By the end, you will carry on a meaningful project outcome, a genuine network, and a front-row view of how Flagship pioneers new ventures that change the world.

• Highly motivated and enthusiastic co-op students eager to dive into groundbreaking research.
• Individuals with a background in molecular biology and cell culture with a desire to master novel techniques. 

• →Conduct immunological assays to assess immune responses elicited by vaccines, using techniques including ELISA, bioluminescent reporter assays, and virus neutralization assays. 
• →Contribute to the development and optimization of novel assays for antigen characterization and vaccine performance evaluation. 
• →Utilize molecular and cell biology methods, such as PCR, NGS, and flow cytometry, to build and screen lenti- and cell-based libraries in multiplexed neutralization assays

• Pursuing a BS or MS in Molecular Biology, Cell Biology, or related field 
• Experience with molecular biology techniques, including DNA/RNA extraction and PCR 
• Experience with cell culture and aseptic technique 
• Experience with virology and viral biosafety (BSL-2) 
• Strong organizational and communication skills 

Embark on an exhilarating journey with Apriori Bio, where your contributions can transform the future of disease prevention. Are you ready to make a difference?